McKesson to sell 28 pharmacies for retail approval of Rexall Health acquisition

To gain regulatory approval for its proposed $3 billion acquisition of Canadian pharmacy chain Rexall Health, McKesson entered a consent agreement with Canada’s Competition Bureau, according to IGDRetailAnalysis.com.

Advertisement

Under terms of the agreement, San Francisco-based McKesson agreed to sell 28 of Mississauga, Ontario-based Rexall’s 470 pharmacies, reports CBC News. The pharmacies are located in communities throughout Ontario, Alberta, Saskatchewan, British Columbia and the Northwest Territories.

In addition, McKesson agreed to contain the exchange of sensitive information between its wholesale business and Rexall’s retail business.

McKesson is Canada’s biggest wholesaler of pharmaceutical products, according to CBC News.

More articles on health IT:
Study: Smartphone-based research provides insight into physical activity, sleep patterns
Rock Health: Digital health reaches ‘tipping point’ in consumer population
18 hidden costs in EHR purchase and implementation

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.